Drawing for DINATEQ

USPTO serial 79386306

DINATEQ

Reviewed by CopyMark Law Group

Reg. 7772611Status 700Registered
Filing date
Status date
Registration date
Apr 29, 2025
Examiner
JANSON, ANDREW KYLE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DINATEQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexander Montgomery

Alexander Montgomery Hinckley Allen & Snyder LLP28 State StreetPostfachBoston, MA 02109

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; medicinal and biomedical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; Biological tissue cultures for medical use; Biological solid organ tissue intended for subsequent implantation; Surgical implants made of living tissue; Biochemical preparations for medical use for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases and cancer; Stem cells for medical use; pharmaceutical, medical, biomedical and veterinary preparations, in particular for the treatment of heart diseasesACTIVE—
009Recorded and downloadable computer software and platforms for data processing, storage and analysis for the development of gene therapies; recorded and downloadable computer software and computer software platforms for data processing, storage and analysis for use in medical, biomedical, veterinary and pharmaceutical research and development; scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, measuring, signaling, detection, testing, inspection, and teaching apparatus and instruments in the nature of high speed cameras, electric sensors and electric actuators, optical 2D scanners, optical filters, and photomultiplier tubes for use in medical, biomedical, veterinary and pharmaceutical research and development; weighing apparatus and instruments for use in medical, biomedical, veterinary and pharmaceutical research and development; Data processing equipment for use in medical, biomedical, veterinary and pharmaceutical research and developmentACTIVE—
010Medical apparatus and instruments for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Surgical apparatus and instruments; Paramedical apparatus and instruments for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Veterinary apparatus and instruments for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Medical instruments for the fusion of medicines, namely, syringes, infusion pumps, syringe systems comprising syringes and medical tubing for administering drugs, intravenous mixing sets consisting of infusion bags sold empty, medical tubing for administering drugs, clamps for securing medical tubing, air filters, and luer connectors, medical laboratory mixers, medical vial reconstitution mixers, nebulizers, medicine autoinjectors sold empty, and balloon catheters; Apparatus for the regeneration of stem cells for medical purposes; Diagnostic apparatus for medical purposes, namely, for medical diagnostic testing related to heart and kidney diseases, except vascular and cardiovascular implants and implanted apparatus; Infusion sets; Artificial biomaterials for the argumentation of cardiac and kidney tissue for medical purposesACTIVE—
035Advertising services; Commercial business administration, organization consulting, and management; Providing office functions; Business management consultancy; Company communication services, namely, public relations and providing business information for potential investors; Consulting services relating to personnel management; Personnel management; providing commercial information in the field of life science, health technology and medical technology; Providing marketing information; drawing up of statements of accounts; Retail store and wholesale store services featuring chemical and medical products and preparations, medical instruments and apparatus, and software in the medical fieldACTIVE—
042Development and programming of computer software and software platforms for others for use in medical, biomedical, veterinary and pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for data processing, storage and analysis for use in medical, biomedical, veterinary and pharmaceutical research and development; Stem cell research services; Consulting services relating to medical, biomedical, veterinary and pharmaceutical research and development; research and development services relating to medical, biomedical, veterinary and pharmaceutical preparations; Providing information about medical, biomedical, veterinary and pharmaceutical scientific research and development; Biological research and analysis, namely, analysis of human tissue for medical, biomedical, veterinary and pharmaceutical research purposes; design and development of medical diagnostic apparatus; Scientific research and development with respect to the isolation and cultivation of human cells and tissues; Programming of computer software for others for information platforms on the Internet for use in medical, biomedical, veterinary and pharmaceutical research and development; Rental of laboratory apparatus and instruments for scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detection, testing, inspection and teaching purposes for use in medical, biomedical, veterinary and pharmaceutical research and development; Rental of computer hardware and data processing equipment for use in medical, biomedical, veterinary and pharmaceutical research and developmentACTIVE—
044Providing medical information in the field of medical care as it relates to the preparation and dispensing medications, in particular for cardiomyopathy, heart failure and kidney diseases; Providing medical information and consulting services in the field of medical care as it relates to medical, biomedical, veterinary and pharmaceutical products; Genetic screening for medical, biomedical, veterinary and pharmaceutical purposes; Human heart and kidney tissue bank services; medical services relating to the removal, treatment and processing of stem cellsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 5, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 15, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 15, 2025FIMPFINAL DISPOSITION PROCESSED—
Jul 29, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 13, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 27, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 27, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 29, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 29, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 14, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 12, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 12, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 12, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 20, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 20, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 20, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 23, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 23, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 23, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2024RFNTREFUSAL PROCESSED BY IB—
Apr 27, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 27, 2024RFRRREFUSAL PROCESSED BY MPU—
Apr 10, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 9, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2024DOCKASSIGNED TO EXAMINER—
Jan 2, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 29, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 28, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance